FDA gives stamp of approval to first LASIK (laser in-situ keratomileusis) laser system
This article was originally published in Clinica
Executive Summary
The FDA has cleared the first excimer laser dedicated to performing laser surgery to correct severe myopia and myopic astigmatism, a technique known as laser in-situ keratomileusis (LASIK).